Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2005; 11(24): 3719-3723
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3719
Table 1 Fas and FasL expression in tissues of gallbladder carcinoma, adenoma and chronic cholecystitis (mean±SE).
Pathological typesnFas+FasL+Apoptosis index
Gallbladder carcinoma261222a3.88±0.88b
Grading
Well-differentiated11792.73±0.75c
Poorly-differentiated155134.73±1.29
Staging
Nevin I–III135102.62±0.68d
Nevin IV–V137125.15±1.33
Gallbladder adenoma1813151.67±0.55
Gallbladder cholecystitis2016110.20±0.18
Table 2 Apoptosis quantities and total quantities of infiltrating lymphocytes in tissues of gallbladder carcinoma, adenoma and chronic cholecystitis (mean±SE).
Pathological typesnTotal quantitiesApoptosis quantities
Gallbladder carcinoma2620.31±4.46b3.96±0.84
Grading
Well-differentiated1111±2.98d2.82±1.15i
Poorly-differentiated1527.13±5.164.8±1.02
Staging
Nevin I–III1313.38±4.28f3.38±1.23
Nevin IV–V1327.23±5.814.54±1.10
Gallbladder adenoma183.89±1.130
Gallbladder cholecystitis201.55±0.54h0